Rooming-in for Infants at Risk for Neonatal Abstinence Syndrome: Outcomes 5 Years following Its Introduction as the Standard of Care at One Hospital
- PMID: 33202425
- PMCID: PMC9270102
- DOI: 10.1055/s-0040-1719182
Rooming-in for Infants at Risk for Neonatal Abstinence Syndrome: Outcomes 5 Years following Its Introduction as the Standard of Care at One Hospital
Abstract
Objective: The practice of rooming-in for opioid-dependent infants was introduced as the standard of care at our hospital following a pilot study which demonstrated that such infants had shorter lengths of stay and were less likely to require pharmacological treatment. We sought to determine whether these benefits have continued, and whether outcomes support continuing to use rooming-in as standard care.
Study design: Opioid-dependent infants delivered at 36 weeks gestation or later between January 1, 2015, and December 31, 2019, were eligible for rooming-in. Charts were reviewed and data were extracted regarding maternal and infant conditions, whether neonatal pharmacological treatment was required, and total length of hospital stay. Outcomes were compared with two historical groups reported in a previous pilot study: 24 healthy near-term opioid-dependent newborns who were admitted directly to the neonatal intensive care unit (NICU) prior to the introduction of rooming-in (May 1, 2012-May 31, 2013), and 20 similar opioid-dependent infants who were the first to room-in at our hospital (September 1, 2013-September 30, 2014).
Results: Only 3.5% of 57 infants who roomed-in during the 5-year study period required pharmacological treatment, compared with 15% who roomed-in during the first year of the program's introduction and 83.3% who had been admitted directly to the NICU. The median length of stay remained 5 days for infants rooming-in, compared with 24 days for opioid-dependent infants in the cohort admitted to the NICU.
Conclusion: Early observations of the benefits of rooming-in on neonatal outcomes were sustained. Infants allowed to room-in were significantly less likely to require initiation of pharmacotherapy and a prolonged hospital stay than similar infants prior to the implementation of rooming-in as standard care. A large proportion of the infants who might have benefited from rooming-in required admission to the NICU for reasons other than neonatal abstinence syndrome (NAS).
Key points: · Benefits of rooming-in for near-term opioid-dependent infants were sustained or increased.. · Rooming-in is sustainable as standard care for these newborns.. · Many infants required admission to NICU for reasons other than NAS..
The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Conflict of interest statement
A.I.N. reports personal fees from Knight Therapeutics, outside the submitted work. All the other authors report no conflict of interest.
Similar articles
-
The Alberta Neonatal Abstinence Syndrome Mother-Baby Care ImprovEmeNT (NASCENT) program: protocol for a stepped wedge cluster randomized trial of a hospital-level Neonatal Abstinence Syndrome rooming-in intervention.BMC Health Serv Res. 2023 May 6;23(1):448. doi: 10.1186/s12913-023-09440-5. BMC Health Serv Res. 2023. PMID: 37149626 Free PMC article.
-
Rooming-in for Infants at Risk of Neonatal Abstinence Syndrome.Am J Perinatol. 2016 Apr;33(5):495-501. doi: 10.1055/s-0035-1566295. Epub 2015 Nov 20. Am J Perinatol. 2016. PMID: 26588259
-
Association of Rooming-in With Outcomes for Neonatal Abstinence Syndrome: A Systematic Review and Meta-analysis.JAMA Pediatr. 2018 Apr 1;172(4):345-351. doi: 10.1001/jamapediatrics.2017.5195. JAMA Pediatr. 2018. PMID: 29404599 Free PMC article.
-
Rooming-in care for infants of opioid-dependent mothers: Implementation and evaluation at a tertiary care hospital.Can Fam Physician. 2015 Dec;61(12):e555-61. Can Fam Physician. 2015. PMID: 27035006 Free PMC article.
-
Nonopioid Management of Neonatal Abstinence Syndrome.Adv Neonatal Care. 2017 Apr;17(2):84-90. doi: 10.1097/ANC.0000000000000371. Adv Neonatal Care. 2017. PMID: 28002062 Review.
Cited by
-
Prenatal opioid-exposed infant extracellular miRNA signature obtained at birth predicts severity of neonatal opioid withdrawal syndrome.Sci Rep. 2022 Apr 8;12(1):5941. doi: 10.1038/s41598-022-09793-7. Sci Rep. 2022. PMID: 35396369 Free PMC article.
-
Addiction in the family: Two Indigenous families overcoming barriers to opioid agonist therapy.Can Fam Physician. 2022 May;68(5):348-351. doi: 10.46747/cfp.6805348. Can Fam Physician. 2022. PMID: 35552202 Free PMC article. No abstract available.
-
Early Postnatal Outcome and Care after in Utero Exposure to Lithium: A Single Center Analysis of a Belgian Tertiary University Hospital.Int J Environ Res Public Health. 2022 Aug 16;19(16):10111. doi: 10.3390/ijerph191610111. Int J Environ Res Public Health. 2022. PMID: 36011745 Free PMC article.
-
Prophylactic dextrose gel use in newborns at risk for hypoglycemia.J Perinatol. 2024 Nov;44(11):1640-1646. doi: 10.1038/s41372-024-02133-9. Epub 2024 Oct 3. J Perinatol. 2024. PMID: 39363038
-
Advances in the Care of Infants With Prenatal Opioid Exposure and Neonatal Opioid Withdrawal Syndrome.Pediatrics. 2024 Jan 1;153(2):e2023062871. doi: 10.1542/peds.2023-062871. Pediatrics. 2024. PMID: 38178779 Free PMC article. Review.
References
-
- Special Advisory Committee on the Epidemic of Opioid Overdoses Opioid-related Harms in Canada Ottawa: Public Health Agency of Canada; March 2020. Accessed August 1, 2020 at:https://health-infobase.canada.ca/substance-related-harms/opioids
-
- Orpana H M, Lang J J, Baxi M. Tendances canadiennes en matière de mortalité liée aux opioïdes et d'invalidité découlant d'un trouble de consommation d'opioïdes, à la lumière de l'Étude sur la charge mondiale de morbidité (1990–2014) Health Promot Chronic Dis Prev Can. 2018;38(06):234–243. - PMC - PubMed
-
- Dawson E, Lew J, Mauer-Vakil D, Van Dijk A, Belanger P, Moore K M. A longitudinal analysis of temporal and spatial incidence of neonatal abstinence syndrome in Ontario: 2003-2016. J Opioid Manag. 2019;15(03):205–212. - PubMed
-
- MacMillan K DL. Neonatal abstinence syndrome: review of epidemiology, care models, and current understanding of outcomes. Clin Perinatol. 2019;46(04):817–832. - PubMed
-
- Stanford Children's Health Neonatal Abstinence SyndromeMay 2020. Available at: https://www.stanfordchildrens.org/en/topic/default?id=neonatal-abstinenc... “https://www.stanfordchildrens.org/en/topic/default?id=neonatal-abstinenc.... Accessed August 1, 2020